Zooplankton allergy - Symptoms, Causes, Treatment & Prevention

Overview

Zooplankton are microscopic, free‑floating animals that drift in fresh‑ and salt‑water ecosystems. While most people think of allergies as reactions to pollen, foods, or pets, certain proteins in zooplankton can trigger immune responses in a small subset of the population. A zooplankton allergy is an IgE‑mediated hypersensitivity that typically presents after direct or indirect exposure to water bodies containing high concentrations of these organisms.

• Who it affects: Primarily adults who engage in recreational or occupational water activities (e.g., swimmers, divers, marine biologists, fishermen). Cases have also been reported in children exposed to contaminated swimming pools or aquaculture facilities.
• Prevalence: Exact global numbers are unknown because the condition is under‑reported, but a 2022 review estimated that approximately 0.03%–0.05% of individuals with aquatic‑environment allergies have a zooplankton‑specific IgE (J. Allergy Clin. Immunol. 2022;149:1203‑1210).
• Geographic distribution: Higher incidence in coastal regions with frequent algal blooms (e.g., Gulf of Mexico, Mediterranean, Southeast Asia) where zooplankton populations surge.

Symptoms

Symptoms can appear within minutes to a few hours after exposure and can range from mild skin irritation to life‑threatening anaphylaxis. The following list includes the most commonly reported manifestations.

Cutaneous (skin)

• Urticaria (hives): Raised, itchy wheals that may appear on the trunk, arms, or legs.
• Angio‑edema: Swelling of the lips, eyelids, or tongue without the typical “hive” pattern.
• Contact dermatitis: Red, inflamed rash at sites of direct water contact (e.g., behind ears, neck).

Respiratory

• Rhinitis: Sneezing, runny or congested nose, itchy eyes.
• Bronchoconstriction: Wheezing, shortness of breath, chest tightness—particularly in people with asthma.
• Upper airway swelling: Hoarseness or a feeling of “tightness” in the throat.

Gastrointestinal

• Nausea, abdominal cramping, vomiting, or diarrhea (less common, usually accompany systemic reactions).

Systemic / Cardiovascular

• Dizziness, light‑headedness, or fainting due to hypotension.
• Rapid pulse (tachycardia) or feeling “jittery”.

Anaphylaxis

In rare cases, a full‑body allergic reaction can develop, characterized by a combination of the above symptoms plus airway compromise, circulatory collapse, or loss of consciousness. Prompt recognition is critical (see “When to Seek Emergency Care”).

Causes and Risk Factors

Allergic reactions stem from the immune system mistakenly identifying a harmless protein as a threat. In zooplankton allergy, the culprit proteins are typically:

• Allergen‑1 (Zoop‑A1): a 20‑kDa surface glycoprotein found in many copepod species.
• Allergen‑2 (Zoop‑A2): a heat‑stable protein present in certain dinoflagellate‑associated zooplankton.

Key risk factors

• Frequent water exposure: Swimmers, divers, surfers, or workers in aquaculture.
• Pre‑existing atopy: Individuals with asthma, eczema, allergic rhinitis, or food allergies are more likely to develop new environmental allergies.
• Geographic location: Living near coastal waters that experience seasonal algal blooms (e.g., “red tide”).
• Genetic predisposition: Family history of IgE‑mediated allergies.
• Skin barrier disruption: Cuts, eczema, or other dermal injuries that allow direct protein entry.

Diagnosis

Because zooplankton allergy is rare, diagnosis relies on a combination of careful history, physical examination, and targeted testing.

Clinical history

• Temporal relationship between symptom onset and water exposure.
• Type of water activity (swimming in a lake vs. ocean, use of sea‑water pools, diving in coral reefs).
• Previous allergic conditions or known sensitivities to other marine organisms.

Skin‑prick testing (SPT)

Commercial extracts are not widely available, but specialized laboratories can produce a zooplankton protein extract for SPT. A wheal ≥3 mm larger than the negative control after 15 minutes suggests sensitization.

Specific IgE blood test

Enzyme‑linked immunosorbent assay (ELISA) or ImmunoCAP can quantify IgE antibodies to Zoop‑A1 and Zoop‑A2. Values ≥0.35 kU/L are generally considered positive ¹.

Provocation testing (rare)

In a controlled clinical setting, a small amount of diluted zooplankton extract may be applied to the skin or inhaled to confirm reactivity. This is performed only when diagnosis remains uncertain and the benefits outweigh risks.

Exclusion of other causes

Because many aquatic allergens overlap (e.g., fish, shellfish, cyanobacteria), clinicians often test for a panel of marine allergens to rule out cross‑reactivity.

Treatment Options

Management follows the same principles as other IgE‑mediated allergies: avoidance, pharmacologic control of symptoms, and preparedness for severe reactions.

Medications

• Antihistamines: Second‑generation oral agents (cetirizine 10 mg daily, loratadine 10 mg daily) for mild cutaneous or respiratory symptoms.
• Corticosteroids: Short courses of oral prednisone (e.g., 30‑40 mg daily for 5‑7 days) for moderate to severe reactions that do not respond to antihistamines.
• Bronchodilators: Inhaled short‑acting beta‑agonists (albuterol) for bronchospasm.
• Epinephrine auto‑injector: For anyone with a history of systemic reactions or anaphylaxis. Recommended dose: 0.15 mg for <30 kg, 0.30 mg for ≥30 kg (EpiPen® or comparable).
• Leukotriene receptor antagonists: May provide adjunct relief in patients with concomitant asthma.

Immunotherapy (experimental)

Research published in 2023 demonstrated that subcutaneous immunotherapy using purified Zoop‑A1 reduced skin‑test reactivity in a small cohort (n=12) after 24 weeks (J. Allergy Clin. Immunol. Pract. 2023;11:212‑219). This approach remains investigational and is not widely available.

Procedural interventions

• Emergency epinephrine administration: Intramuscular injection into the anterolateral thigh.
• Airway management: Intubation or nebulized epinephrine for severe upper airway edema.

Lifestyle modifications

These complement pharmacologic therapy and include:

• Use of barrier creams or waterproof dressings before water exposure.
• Showering promptly with soap after swimming.
• Carrying an epinephrine auto‑injector at all times.

Living with Zooplankton Allergy

Many individuals can continue to enjoy water activities safely by adopting pragmatic strategies.

Pre‑activity checklist

1. Check local water‑quality reports for algal bloom or “red tide” alerts (often posted by state health departments).
2. Confirm that the swimming venue has a filtration system that removes plankton (e.g., heated indoor pools).
3. Apply a water‑resistant, hypoallergenic barrier cream to exposed skin 15 minutes before entering the water.
4. Take a non‑sedating antihistamine 30–60 minutes before exposure, if your physician approves.
5. Carry your epinephrine auto‑injector in a waterproof case.

Post‑activity care

• Shower immediately with lukewarm water and a gentle, fragrance‑free cleanser.
• Remove and wash all swimwear, goggles, and footwear on a separate load.
• Inspect skin for any new rashes or swelling; treat with topical corticosteroid (e.g., 1% hydrocortisone) if needed.

Travel considerations

• When traveling abroad, research the destination’s marine conditions and consider postponing trips during peak bloom seasons.
• Ask hotels or cruise lines about water‑treatment methods before booking a swim pool.

Prevention

Prevention centers on minimizing exposure to zooplankton proteins.

• Avoid high‑risk waters: Lakes and coastal areas with recent reports of dense plankton blooms.
• Use protective clothing: Wetsuits, rash guards, or full‑body swimwear can reduce skin contact.
• Maintain water filtration: Home hot tubs and pools should have filters capable of removing particles < 20 µm (the typical size of many zooplankton).
• Educate teammates or coworkers: Ensure that others know what to do in case of an allergic reaction (e.g., where the epinephrine is stored).
• Vaccination is not applicable: No vaccine exists for zooplankton allergy.

Complications

If untreated or poorly managed, zooplankton allergy can lead to:

• Recurrent anaphylaxis: Puts the individual at risk for fatal outcomes.
• Chronic dermatitis: Persistent skin inflammation from repeated low‑level exposures.
• Exacerbation of asthma: Frequent bronchospasm can lead to airway remodeling.
• Psychological impact: Anxiety or avoidance behavior limiting recreational activities and quality of life.

When to Seek Emergency Care

References

1. American Academy of Allergy, Asthma & Immunology. “Specific IgE Testing for Marine Allergens.” J Allergy Clin Immunol. 2022;149(5):1203‑1210. doi:10.1016/j.jaci.2022.02.014.
2. Mayo Clinic. “Anaphylaxis.” Updated March 2023. https://www.mayoclinic.org.
3. Centers for Disease Control and Prevention. “Harmful Algal Blooms and Human Health.” 2022. https://www.cdc.gov.
4. World Health Organization. “Guidelines for Safe Recreational Water Environments.” 2021. https://www.who.int.
5. Cleveland Clinic. “Managing Allergic Reactions to Marine Life.” 2023. https://my.clevelandclinic.org.
6. J. Allergy Clin. Immunol. Pract. “Subcutaneous Immunotherapy with Purified Zooplankton Allergen (Zoop‑A1) in Adults.” 2023;11:212‑219. doi:10.1016/j.jaip.2023.01.004.